Pages that link to "Q37850992"
Jump to navigation
Jump to search
The following pages link to Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan (Q37850992):
Displaying 39 items.
- Transarterial radioembolization for hepatocellular carcinoma: a review (Q26738273) (← links)
- Current and future treatments for hepatocellular carcinoma (Q26801211) (← links)
- Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments (Q26852174) (← links)
- Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective (Q26998661) (← links)
- Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives (Q27023616) (← links)
- Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives (Q28081783) (← links)
- Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres (Q28083185) (← links)
- Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization. (Q30364718) (← links)
- Dosimetry for radiopharmaceutical therapy (Q33665116) (← links)
- Optimal design of anger camera for bremsstrahlung imaging: monte carlo evaluation (Q33751252) (← links)
- Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization (Q34584472) (← links)
- Mitigation of Lethal Radiation Syndrome in Mice by Intramuscular Injection of 3D Cultured Adherent Human Placental Stromal Cells (Q34792336) (← links)
- Yttrium-90 microsphere radioembolization for hepatocellular carcinoma (Q35631304) (← links)
- Increased absorbed liver dose in Selective Internal Radiation Therapy (SIRT) correlates with increased sphere-cluster frequency and absorbed dose inhomogeneity (Q35985132) (← links)
- Lobar hepatocellular carcinoma with ipsilateral portal vein tumor thrombosis treated with yttrium-90 glass microsphere radioembolization: preliminary results (Q36651407) (← links)
- A review of 3D image-based dosimetry, technical considerations and emerging perspectives in (90)Y microsphere therapy (Q36899620) (← links)
- Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept (Q36920698) (← links)
- Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives (Q37068157) (← links)
- Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres (Q37071558) (← links)
- High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90 Y-loaded glass microsphere radioembolization. (Q37565602) (← links)
- SIRT of liver metastases: physiological and pathophysiological considerations (Q38026766) (← links)
- The role of SPECT/CT in radioembolization of liver tumours. (Q38180004) (← links)
- The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy (Q38219225) (← links)
- Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology. (Q38538075) (← links)
- Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases (Q39761939) (← links)
- Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis (Q40444455) (← links)
- 18F-fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma (Q46775794) (← links)
- Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma. (Q47410201) (← links)
- Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: From clinical aspects to dosimetry (Q47665576) (← links)
- The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE) (Q57153173) (← links)
- Rescue from lethal acute radiation syndrome (ARS) with severe weight loss by secretome of intramuscularly injected human placental stromal cells (Q58597753) (← links)
- The SIRveNIB and SARAH trials, radioembolization . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future (Q60922505) (← links)
- EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds (Q61827005) (← links)
- Radioembolisation of hepatocellular carcinoma patients using ⁹⁰Y-labelled microspheres: towards a diffusion of the technique? (Q85066075) (← links)
- Radioembolization with (90)Y-loaded microspheres: high clinical impact of treatment simulation with MAA-based dosimetry (Q87255507) (← links)
- A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy (Q88115617) (← links)
- Nuclear Theranostics in Taiwan (Q91776826) (← links)
- Analysis of differences between 99mTc-MAA SPECT- and 90Y-microsphere PET-based dosimetry for hepatocellular carcinoma selective internal radiation therapy (Q92096193) (← links)
- Radionuclide therapy: current status and prospects for internal dosimetry in individualized therapeutic planning (Q92312269) (← links)